Orchasp Limited has announced significant board-level changes following its board meeting held on March 6, 2026. The company has appointed a new Independent Director and reconstituted its board committees to strengthen corporate governance and oversight mechanisms, as communicated to BSE Limited and The National Stock Exchange of India Limited under Regulation 30 of SEBI (LODR) Regulations, 2015.

Independent Director Appointment

The board of directors, based on the recommendation of the Nomination and Remuneration Committee, approved the appointment of Mr. Ravi Prasad Muthyam (DIN: 06603818) as an additional director designated as an Independent Director. The appointment details are structured as follows:

Professional Background

Mr. Ravi Prasad Muthyam brings extensive expertise to the board with over 26 years of combined experience in the banking and financial services sector. His professional journey includes:

• Banking Experience: 11 years with reputed banking and financial institutions
• Consulting Experience: Over 15 years as a professional financial consultant
• Educational Background: MBA in Business Management
• Current Role: Director at Moneytree Corp Consulting India Private Limited since 2013

His company has been successfully providing financial consultancy and assisting corporates in fundraising activities across India. Mr. Muthyam has extensive experience in banking operations, financial advisory, and corporate funding. The company confirmed that he is not related to any other director and is not debarred from holding the office of director by any regulatory authority.

Board Committee Reconstitution

Following the new appointment, Orchasp Limited has reconstituted its board committees effective March 6, 2026. The new committee compositions are:

Audit Committee

Nomination and Remuneration Committee

Stakeholders Relationship Committee

Corporate Social Responsibility Committee

Meeting Details and Compliance

The board meeting was conducted on Friday, March 6, 2026, commencing at 03:00 PM IST and concluding at 05:00 PM IST. The decisions were communicated to both BSE Limited and The National Stock Exchange of India Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has made the information available on its website at www.orchasp.com and submitted all required documentation to the stock exchanges for record. The communication was digitally signed by P. Chandra Sekhar, Managing Director & CFO (DIN: 01647212).

Orchasp Limited has successfully launched its electronic health records platform INDUSAYUSH on the Apple App Store, marking a significant milestone in the company's digital healthcare expansion. The announcement was made on February 24, 2026, through a regulatory filing under SEBI's disclosure requirements.

Platform Launch Details

The company formally disclosed the development pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The INDUSAYUSH platform has been admitted to the Apple App Store with effect from February 24, 2026, making it accessible to iOS users worldwide.

Official Apple Confirmation

Apple has officially confirmed the app's approval through App Store Connect, congratulating Orchasp Limited on the successful distribution approval. The tech giant noted that while the app has been approved, it can take up to 24 hours for applications to become fully available on the App Store after release.

The approval email from Apple's App Review team emphasized the global reach opportunity that the App Store provides, highlighting features such as:

• App Analytics for measuring user engagement
• Marketing guidelines for App Store promotion
• Search Ads capabilities for enhanced visibility

Digital Healthcare Expansion

The INDUSAYUSH platform represents Orchasp Limited's strategic move into the digital healthcare sector, specifically focusing on electronic health records management. The platform's availability on iOS devices expands the company's potential user base significantly, given Apple's substantial market presence in the mobile ecosystem.

The regulatory filing was signed by P. Chandra Sekhar, Managing Director & CFO (DIN: 01647212), emphasizing the strategic importance of this development for the company's stakeholders and investors.

Market Implications

With the INDUSAYUSH app now available on Apple's platform, Orchasp Limited positions itself to compete in the growing digital health records market. The Apple App Store's global distribution network provides the company with immediate access to millions of potential users across international markets, potentially driving user adoption and revenue growth in the healthcare technology segment.